![]() |
市场调查报告书
商品编码
1447098
Caralluma 萃取物市场预测至 2030 年:按形式、成分、分销管道、应用、最终用户和地区进行的全球分析Caralluma Extract Market Forecasts to 2030 - Global Analysis By Form, Ingredient, Distribution Channel, Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球卡拉卢马萃取物市场在预测期内将以 5.1% 的复合年增长率成长。
Caralluma 萃取物是从原产于印度的 Caralluma fimbriata 植物中提取的。它传统上在印度文化中因其抑制食慾的特性而被使用。人们认为这种萃取物透过影响大脑中调节食慾的特定神经传导物质而发挥作用。 Caralluma 萃取物富含抗氧化剂,具有促进心血管健康和调节血糖值等健康益处。
根据 William Reed Business Media Ltd. 2016 年发布的资料,大约 79% 的欧洲人愿意为有机补充品等产品金额更多费用,因为我希望他们对改善整体健康更感兴趣。
对天然和植物来源成分的需求不断增加
消费者越来越多地寻求合成补充品的替代品,并青睐卡拉鲁玛等萃取物,因为它们被认为对健康有益且安全。这一趋势是由健康意识的增强以及对符合永续和环保生活方式的产品的渴望所推动的。因此,卡拉卢马萃取物作为体重管理和食慾抑制的天然解决方案越来越受欢迎,推动市场成长并增加其在营养补充食品的影响力。
对有效性的担忧
围绕萃取物萃取物的功效问题主要围绕着个体反应和有限的长期研究。儘管科学研究表明它可能对体重管理和抑制食慾有效,但使用者之间的结果不一致,并且尚未进行大型临床试验,因此消费者普遍持怀疑态度。如果没有确切的证据证明对所有人都有效,消费者可能会选择替代产品,从而抑制市场成长。
扩大营养补充食品
由于人口变化和健康意识食品等因素,营养补充产业经历了强劲成长,Caralluma 萃取物正在成为一种受欢迎的产品。这一市场扩张为 Caralluma 萃取物提供了满足更广泛消费者群体的机会,鼓励创新和产品多样化。因此,蓬勃发展的营养补充市场起到了催化剂的作用,使 Caralluma 萃取物在天然保健补充品的竞争格局中处于有利地位。
来自合成替代品的竞争
由于合成减重药和食慾抑制剂具有见效更快和市场地位稳固等优势,一些消费者对于选择天然替代品(如卡拉卢马萃取物)则犹豫不决。此外,合成替代品的积极行销和製药公司的支持可能会掩盖卡拉卢马萃取物的好处并限制市场渗透。这种竞争已成为Caralluma萃取物的进入壁垒,阻碍了市场的扩展和普及。
COVID-19 的影响
COVID-19 大流行造成供应链中断,导致供应和价格波动,从而影响了卡拉卢马萃取物市场。由于当地的封锁措施和消费者的购买行为,消费者对含有卡拉卢马萃取物的保健补充食品的需求既激增又下降。然而,大流行期间人们对健康和保健意识的增强也推动了市场的成长,因为消费者寻求自然疗法来支持他们的免疫系统和整体健康。
预计粉末细分市场在预测期内将是最大的
预计粉末市场将出现良好的成长。 Caralluma 萃取物粉末因其在体重管理和抑制食慾方面的潜在益处而受到健康和保健行业的青睐。这种粉末型态可以轻鬆融入各种产品中,如饮料、冰沙和营养补充,提供多种消费方式。其方便的形式和可感知的有效性使其成为营养补充食品的热门选择,推动了全球需求的成长。
预计营养补充食品在预测期内复合年增长率最高
由于其潜在的食慾抑制特性,营养补充食品预计在预测期内将出现最高的复合年增长率。 Caralluma 萃取物是体重管理产品中的流行成分。 Caralluma 萃取物被认为是透过影响下丘脑发挥作用,从而调节饥饿水平。此外,它可能会抑制某些参与脂肪生成的酵素的活性。将其纳入营养补充食品了其在支持健康体重管理目标和促进整体健康方面的作用。
由于消费者偏好的增加和收入水准的提高,预计北美在预测期内将呈现最高的复合年增长率。该地区食品营养补充,加上肥胖率的上升,增加了对卡拉卢马萃取物的需求。此外,强调天然来源和健康益处的策略行销工作继续推动北美卡拉卢马萃取物市场的扩张。
由于健康意识的提高和肥胖相关问题的盛行率上升,预计亚太地区在预测期内将占据最大的市场占有率。像印度这样的国家,Caralluma fimbriata 的原产地,由于其传统用途和文化接受度,需求量庞大。此外,中国和日本等国家的食品营养补充正在快速成长,进一步推动了卡拉卢玛萃取物的采用。由于城市人口的增加和向自然疗法的转变,预计亚太地区卡拉卢马萃取物市场将持续扩大。
According to Stratistics MRC, the Global Caralluma Extract Market is growing at a CAGR of 5.1% during the forecast period. Caralluma extract is derived from the Caralluma fimbriata plant, native to India. It has been traditionally used in Indian culture for its appetite-suppressing properties. This extract is believed to work by affecting certain neurotransmitters in the brain that regulate appetite. Caralluma extract is rich in antioxidants and also offers health benefits such as improved cardiovascular health and blood sugar regulation.
According to data published by William Reed Business Media Ltd. in 2016, approximately 79% of Europeans are willing to pay more for products, such as organic supplements, owing to greater interest in improving overall wellbeing.
Growing demand for natural and plant-based ingredients
Consumers are increasingly seeking alternatives to synthetic supplements, favouring botanical extracts like caralluma for their perceived health benefits and safety. This trend is fuelled by growing health consciousness and a desire for products that align with sustainable and environmentally friendly lifestyles. As a result, caralluma extract is experiencing rising popularity as a natural solution for weight management and appetite control, driving market growth and expanding its presence in the dietary supplements industry.
Efficacy concerns
Efficacy concerns surrounding Caralluma Extract primarily revolve around varying individual responses and limited long-term studies. While scientific research suggests its potential benefits for weight management and appetite suppression, inconsistent results among users and a lack of extensive clinical trials raise skepticism among consumers. Without conclusive evidence demonstrating its effectiveness for all individuals, consumers may opt for alternative products, inhibiting the growth of the market.
Expanding dietary supplements market
With the dietary supplements sector experiencing robust growth, fuelled by factors like shifting demographics and health-conscious lifestyles, caralluma extract emerges as a sought-after product. This market expansion fosters opportunities for caralluma extract to cater to a broader consumer base, prompting innovation and product diversification. Thus, the flourishing dietary supplements market acts as a catalyst, positioning caralluma extract favourably within the competitive landscape of natural health supplements.
Competition from synthetic alternatives
Synthetic weight loss medications and appetite suppressants offer perceived advantages, such as faster results and established market presence, deterring some consumers from opting for natural alternatives like caralluma extract. Additionally, aggressive marketing and pharmaceutical backing of synthetic alternatives can overshadow the benefits of caralluma extract, limiting its market penetration. This competition creates barriers to entry for caralluma extract, hindering its market expansion and adoption.
Covid-19 Impact
The covid-19 pandemic has impacted the caralluma extract market by causing disruptions in the supply chain, leading to fluctuations in availability and pricing. Consumer demand for health supplements, including caralluma extract, has seen both spikes and declines depending on regional lockdown measures and consumer purchasing behaviour. However, increased awareness of health and wellness during the pandemic has also driven some growth in the market as consumers seek natural remedies to support their immune systems and overall well-being.
The powder segment is expected to be the largest during the forecast period
The powder segment is estimated to have a lucrative growth. Caralluma extract powder is gaining traction in the health and wellness industry for its potential benefits in weight management and appetite suppression. This powdered form offers versatility in consumption, allowing easy incorporation into various products such as beverages, smoothies, and dietary supplements. Its convenient form factor and perceived effectiveness make it a popular choice in the dietary supplements market, driving its growing demands globally.
The dietary supplements segment is expected to have the highest CAGR during the forecast period
The dietary supplements segment is anticipated to witness the highest CAGR growth during the forecast period, due to its potential appetite-suppressing properties. It is a popular ingredient in weight management products. Caralluma extract is believed to work by affecting the hypothalamus, which regulates hunger levels. Additionally, it may inhibit the activity of certain enzymes involved in fat production. Its inclusion in dietary supplements underscores its role in supporting healthy weight management goals, promoting overall wellness.
North America is projected to have the highest CAGR over the forecast period, owing to the increasing consumer preferences and rising income levels. The region's robust dietary supplements market, coupled with rising obesity rates, contributes to the demand for caralluma extract. Further, strategic marketing efforts emphasizing its natural origins and health benefits continue to fuel the expansion of the Caralluma Extract market in North America.
Asia Pacific is projected to hold the largest market share during the forecast period owing to increasing health consciousness and the rising prevalence of obesity-related issues. Countries like India, where caralluma fimbriata is native, witness significant demand due to its traditional use and cultural acceptance. Moreover, the burgeoning dietary supplements market in countries like China and Japan further propels the adoption of caralluma extract. With expanding urban populations and a shift towards natural remedies, the Asia-Pacific caralluma extract market is poised for continued expansion.
Key players in the market
Some of the key players profiled in the Caralluma Extract Market include Bio Nutrition Inc., Creative Bioscience, Gencor Pacific Group, Nutra Rise, BioGenetic Laboratories, Pure Encapsulations, Source Naturals, Swanson Health Products, NOW Foods, Solaray, Sabinsa Corporation, Natreon Inc., NutraMarks Inc. and Novel Nutrients Private Limited.
In February 2021, Gencor launched Caralluma fimbriata extract for stress and anxiety. The ingredient has been studied in animals and humans, including a double-blind, randomized clinical trial with 97 adults self-reporting mild to moderate anxiety.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.